Imaging Tumor Response to Therapy

Measurement of solid tumor response to treatment relies mainly on imaging. WHO tumor response criteria and, more recently, RECIST (response evaluation criteria in solid tumors) have provided means to objectively measure tumor response in clinical trials with imaging. These guidelines have been rapid...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Aglietta, Massimo (Editor ), Regge, Daniele (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Milano : Springer Milan : Imprint: Springer, 2012.
Edición:1st ed. 2012.
Temas:
Radiology.
Oncology.
Nuclear medicine.
Nuclear Medicine.
Acceso en línea:Texto Completo

MARC

LEADER 00000nam a22000005i 4500
001 978-88-470-2613-1
003 DE-He213
005 20220115232030.0
007 cr nn 008mamaa
008 120714s2012 it | s |||| 0|eng d
020 |a 9788847026131  |9 978-88-470-2613-1 
024 7 |a 10.1007/978-88-470-2613-1  |2 doi 
050 4 |a R895-920 
072 7 |a MMP  |2 bicssc 
072 7 |a MED008000  |2 bisacsh 
072 7 |a MKS  |2 thema 
082 0 4 |a 616.0757  |2 23 
245 1 0 |a Imaging Tumor Response to Therapy  |h [electronic resource] /  |c edited by Massimo Aglietta, Daniele Regge. 
250 |a 1st ed. 2012. 
264 1 |a Milano :  |b Springer Milan :  |b Imprint: Springer,  |c 2012. 
300 |a XVII, 157 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a Part I Methodological Bases -- 1 Surrogate Endpoints of Clinical Benefit -- 2 Response to Treatment: the Role of Imaging -- Part II RECIST and Beyond: Assessing the Response to Treatment in Metastatic Disease -- 3 Gastrointestinal Stromal Tumors -- 4 Renal Cancer -- 5 Liver Metastases in Colon Cancer -- Part III RECIST and Beyond: Assessing the Response to Treatment in Locally Advanced Disease -- 6 Neoadjuvant Therapy in Breast Cancer -- 7 Lung Cancer -- 8 Pancreatic Cancer -- 9 Hepatocellular Carcinoma. 
520 |a Measurement of solid tumor response to treatment relies mainly on imaging. WHO tumor response criteria and, more recently, RECIST (response evaluation criteria in solid tumors) have provided means to objectively measure tumor response in clinical trials with imaging. These guidelines have been rapidly adopted in clinical practice to monitor patient treatment and for therapy planning. However, relying only on anatomical information is not always sufficient when evaluating new drugs that will reduce a tumor's functionality while preserving its size. Finding more reliable and reproducible measures of tumor response is one of the most important and difficult challenges facing modern radiology as it requires an entirely new approach to imaging. The aim of this book is to address the assessment of response to treatment by adopting a multidisciplinary perspective, just as occurs in real life in a comprehensive cancer center. Oncologists and imaging experts consider two cancer models, locally advanced disease and metastatic disease, jointly exploring both conventional and advanced means of measuring response to standard treatment protocols and new targeted therapies. 
650 0 |a Radiology. 
650 0 |a Oncology. 
650 0 |a Nuclear medicine. 
650 1 4 |a Radiology. 
650 2 4 |a Oncology. 
650 2 4 |a Nuclear Medicine. 
700 1 |a Aglietta, Massimo.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Regge, Daniele.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9788847026124 
776 0 8 |i Printed edition:  |z 9788847026148 
776 0 8 |i Printed edition:  |z 9788847039223 
856 4 0 |u https://doi.uam.elogim.com/10.1007/978-88-470-2613-1  |z Texto Completo 
912 |a ZDB-2-SME 
912 |a ZDB-2-SXM 
950 |a Medicine (SpringerNature-11650) 
950 |a Medicine (R0) (SpringerNature-43714) 

Ejemplares similares